GlaxoSmithKline Statements
GL
GlaxoSmithKline Income Statement
B
M
INR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
17 350.6
100
6 839.7
39.5
10 510.9
60.5
—
0
3 141.8
18.6
6 109.8
34.8
4 401.1
25.7
-10.9
-0.08
579.4
3.2
3 360.5
29.1
958.5
8.2
2 402
20.9
14.18
169.37
17 186.5
100
6 505.6
37
10 680.9
63
—
0
3 102.1
15.2
6 691.9
34.6
3 989
28.4
-7.1
-0.04
646.5
2.9
4 801.4
31.3
1 303.8
8.5
3 497.6
22.7
20.65
169.37
15 897.53
100
6 328.76
43.8
9 568.77
56.2
—
0
3 018.26
18.9
5 920.27
36.8
3 648.49
19.4
-7.422
-0.08
510.81
3.5
4 142.2
24.1
1 162.28
7.2
2 979.87
16.9
17.589
169.43
16 619.7
100
6 520
39.8
10 099.7
60.2
—
0
2 931.6
15.5
6 363
33.9
3 736.7
26.2
-10.7
-0.04
495.8
2.4
4 221.8
28.6
1 125.3
7.5
3 127
21.1
18.46
169.4
16 255.5
100
6 715.2
43.4
9 540.3
56.6
—
0
2 824.3
17.3
6 142.2
36.9
3 398.1
19.7
-8.6
-0.03
290.8
2.3
3 796.1
25.7
2 959.9
32.4
13 694
150.6
80.84
169.35
16 524.9
100
6 846.7
41.6
9 678.2
58.4
—
0
3 278
17.1
6 120.2
32.6
3 558
25.8
-11.4
-0.04
467
1.6
4 013.6
27.3
1 032.4
6.9
3 253.2
21.9
19.2
169.35
13 976.9
100
6 320.5
52
7 656.4
48
—
0
3 102.3
27.9
5 213.1
37.6
2 443.3
10.5
-15.7
-0.1
436.2
5.5
1 779.1
-6.2
779.5
4.3
1 708.4
2.7
10.08
169.45
15 279.1
100
6 248
41.8
9 031.1
58.2
—
0
3 059.3
17.5
6 279.1
37.4
2 752
20.8
-19.6
-0.1
669.6
1
2 760.7
14.4
887.7
5.7
1 873
8.7
11.05
169.55
15 543.9
100
6 072.1
36
9 471.8
64
—
0
3 382.7
22.1
6 901.5
44.5
2 570.3
19.5
-44.9
-0.2
323.2
2
-4 577.7
22.8
484
5
-5 230.9
17.8
-30.88
169.55
16 699.9
100
7 006.6
41.9
9 693.3
58.1
—
0
2 902.8
16.7
6 517.9
38.6
3 175.4
19.4
-18.5
-0.1
466.9
1.8
7 635.2
66.6
1 472.3
9.6
6 162.9
57
36.38
169.45